PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
29-Mar-2021 The PROTECT-V trial investigating UNIONs COVID-19 candidate receives Urgent Public Health Prioritization from the UK government UNION therapeutics A/S
29-Mar-2021 HUTCHMED Initiates International Phase I Trials of IDH1/2 Dual Inhibitor in Patients with Advanced Solid Tumors or Hematological Malignancies HUTCHMED
29-Mar-2021 OKYO Pharma Limited ("OKYO" or the "Company") - OKYO announces appointment of Dr Rajkumar Patil as Chief Scientific Officer OKYO Pharma Limited
29-Mar-2021 Instant Covid Tests London to launch first test centre using 20-second Virolens technology Instant Covid Tests London (ICTL)
29-Mar-2021 Syncona cornerstones $148 million Series C Financing in Gyroscope Syncona Ltd
29-Mar-2021 Vertex Receives Australian TGA Approval for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Treat People With Cystic Fibrosis Ages 12 Years and Older Who Have At Least One F508del Mutation Vertex Pharmaceuticals Incorporated
29-Mar-2021 Gadopiclenol: positive results for Phase III clinical trials Guerbet
29-Mar-2021 Avifavir obtains its first registration in Asia Russian Direct Investment Fund
29-Mar-2021 PrecisionLife continues growth and expansion with acquisition of Danish genomic analytics innovator GenoKey PrecisionLife
29-Mar-2021 HUTCHMED Initiates a Phase Ib/II Trial of Surufatinib in Combination with Tislelizumab in Patients with Advanced Solid Tumors Hutchison China MediTech Limited
29-Mar-2021 Molecular ‘cookie cutter’ technique could provide key for COVID drug discovery University of Birmingham
29-Mar-2021 LEO Foundation and Nordic Capital partner up to further strengthen LEO Pharma’s leading position in medical dermatology Nordic Capital
29-Mar-2021 Amzell BV appoints new Chairman and CEO as its portfolio of product development candidates approach Phase 3 trials Amzell BV
29-Mar-2021 Qlucore announces major new release (3.7) with ChIP-seq and Biomarker support Qlucore
29-Mar-2021 Augustine Therapeutics awarded EUR 1.2 million VLAIO research grant to develop new medicines for neuromuscular diseases Augustine Therapeutics
29-Mar-2021 DUNAD THERAPEUTICS EMERGES TO DEVELOP NEXT-GENERATION SMALL MOLECULE THERAPEUTICS BASED ON FIRST TUNEABLE TARGETED PROTEIN DEGRADATION TECHNOLOGY Dunad Therapeutics
29-Mar-2021 Yposkesi to give talk on gene therapy vectors at Virtual Cell & Gene Meeting on the Mediterranean, April 6 – 9, 2021 Andrew Lloyd Associates
29-Mar-2021 Cell-Easy strengthens executive team with two new highly experienced members Andrew Lloyd Associates
29-Mar-2021 Independent Peer-Reviewed Study Validates Therapeutic Mode of Action of Cardior's First-in-Class Heart Failure Program Cardior Pharmaceuticals
26-Mar-2021 BioNTech provides Update on Vaccine Production Status at Marburg Manufacturing Site BioNTech